about
High degree of heterogeneity in Alzheimer's disease progression patternsHigher working memory predicts slower functional decline in autopsy-confirmed Alzheimer's diseaseCalculating stage duration statistics in multistage diseasesVascular risk as a predictor of cognitive decline in a cohort of elderly patients with mild to moderate dementia.Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting.Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease.For debate: substituting placebo controls in long-term Alzheimer's prevention trials.Predictors of long-term cognitive outcome in Alzheimer's diseaseRisk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).Alzheimer's disease progression by geographical region in a clinical trial settingTest-retest reliability of memory task functional magnetic resonance imaging in Alzheimer disease clinical trials.Learning Biomarker Models for Progression Estimation of Alzheimer's Disease.Plasma microRNA biomarkers for detection of mild cognitive impairment.Factors that influence survival in a probable Alzheimer disease cohort.Profiling of Alzheimer's disease patients in Puerto Rico: A comparison of two distinct socioeconomic areas.Clinical, imaging, and pathological heterogeneity of the Alzheimer's disease syndrome.Modeling the course of Alzheimer's disease to improve clinical trials: symposium reportProgression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies.Cerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future.Rapid cognitive decline in Alzheimer's disease: a literature review.Long-Term Care Service Trajectories and Their Predictors for Persons Living With Dementia: Results From a Canadian Study.Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment.Severe, Persistent and Fatal Delirium in Psychogeriatric Patients Admitted to a Psychiatric HospitalEarly- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.Personalized predictive modeling for patients with Alzheimer's disease using an extension of Sullivan's life table model.Correction: Predicting progression of Alzheimer's disease.Mild traumatic brain injury is associated with reduced cortical thickness in those at risk for Alzheimer's disease.Rapidly Versus Slowly Progressing Patients With Alzheimer's Disease: Differences in Baseline Cognition.Predictors of rapid cognitive decline in Alzheimer's disease: results from the Australian imaging, biomarkers and lifestyle (AIBL) study of ageing.The importance of endpoint selection: How effective does a drug need to be for success in a clinical trial of a possible Alzheimer's disease treatment?
P2860
Q28477810-6531DFAF-788B-4BBF-BF97-B4C801631128Q34076179-EB1FDC45-BBC5-431D-9FA6-C31CE9896A5FQ34098173-7C816552-D83D-492E-A1DA-F26E6A7D7C38Q34632722-F61E9B53-4B39-465B-9DC3-38B074182EF0Q35327053-2DF5C751-3944-4409-A001-FC74AB48A089Q35555867-C909BCE3-3B21-4DEF-AF22-3CA806223BC3Q35579221-63993C23-5787-4A96-9BD7-412646D68434Q35579243-BDA8DA23-49C0-4CEA-9D3E-3B9A1D3A99E5Q35693632-1AEBF1B1-28BA-4E7D-A9EF-BD48FACE3287Q35782628-59FC2263-2D66-469F-84AB-861AB7EEEF58Q35793076-3A097B07-5B8A-487C-8A4D-FC05F90B821DQ35994766-F958C08A-A7BD-423C-94C0-6EA68F0DAC65Q36380583-AF9EBD37-B2BF-4BAD-A158-0AB1DA8ACF2EQ36424811-036AA779-314C-4BC9-B42D-58343C1FA6D7Q36535071-935E7A53-3E46-4D40-9A5F-AC02C7924D81Q36632706-68C2EDF8-2AB3-4C4D-A742-89E1012E7AB5Q36998328-71753E52-817E-4E74-A4BB-56DF4247BA85Q37690649-3BAF9DBD-C58D-4DCD-BE82-06D1EFAC9FEDQ37895052-61105E2F-A8B1-4186-9A21-996DD2A37C19Q38178371-C0605DE6-0BE2-4740-8478-A08B77232D77Q38621776-A8A88BAB-1B1F-4BAD-989E-3CBDD100587EQ39183032-76092EB2-DD5F-484B-8D14-A5E4727F117DQ40713901-5A948D52-465C-43C3-A942-F4AFF9DFCB20Q41588156-4F0AB9C2-3A20-4FD9-A109-6452A3E03157Q41695288-2E669490-ED96-43CF-A43C-B7C572421D08Q42059269-DAC0C233-4538-45A1-8E70-DA6C15774C06Q47995215-B0CE4A8B-DEDB-43F8-90C0-A7332C87321DQ50689821-75B8AFDA-BA28-43D7-BF2F-1778B6110201Q50794557-94245A4D-4303-45E7-AC37-D802F7870BEBQ54249538-0817B494-1B00-47E1-AF1B-8B9E5F3E14D0
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Predicting progression of Alzheimer's disease.
@ast
Predicting progression of Alzheimer's disease.
@en
type
label
Predicting progression of Alzheimer's disease.
@ast
Predicting progression of Alzheimer's disease.
@en
prefLabel
Predicting progression of Alzheimer's disease.
@ast
Predicting progression of Alzheimer's disease.
@en
P2093
P2860
P356
P1476
Predicting progression of Alzheimer's disease.
@en
P2093
Eveleen Darby
Paul Massman
Rachelle S Doody
Susan Rountree
Valory Pavlik
Wenyaw Chan
P2860
P2888
P356
10.1186/ALZRT25
P407
P577
2010-02-23T00:00:00Z
P5875
P6179
1038865601